Chemotherapy Tyrosine Kinase Inhibitors Immunotherapy EGFR Other CD Protein Inhibitors Kinase Inhibitors | Colorectal Cancer | HER2 Positive Breast Cancer | Breast Cancer | Renal Cell Carcinoma | Prostate Cancer | Ovarian Cancer | Lung Cancer | Estrogen Receptor Positive Breast Cancer | Solid Tumor | Endometrial Cancer | Bladder Cancer | Melanoma | Pancreatic Cancer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ado-trastuzumab emtansine | |||||||||||||
U3-1402 | |||||||||||||
cetuximab | |||||||||||||
Ac-225 ErbB3 targeted radiotherapy | |||||||||||||
177Lu-satetraxetan-lilotomab | |||||||||||||
DB-1310 | |||||||||||||
U3-1402 + BAY 1895344 | |||||||||||||
HMBD-501 | |||||||||||||
AMT-562 | |||||||||||||
lapatinib | |||||||||||||
afatinib | |||||||||||||
pertuzumab |